A small allelic variant in donor class I MHC is sufficient to induce alloantibodies following transfusion of standard or pathogen‐reduced platelets in mice-Reference-Cited by-同舟云学术

A small allelic variant in donor class I MHC is sufficient to induce alloantibodies following transfusion of standard or pathogen‐reduced platelets in mice

Published:2020-03-23 Issue:5 Volume:115 Page:367-376
ISSN:0042-9007
Container-title:Vox Sanguinis
language:en
Short-container-title:Vox Sang

Author:

Jackman Rachael P.¹²^ORCID,Heitman John W.¹,Muench Marcus O.¹²^ORCID

Affiliation:

1. Vitalant Research Institute San Francisco California USA

2. University of California San Francisco California USA

Funder

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vox.12897

Reference32 articles.

1. The natural history of alloimmunization to platelets

2. Preformed IgG Antibodies Against Major Histocompatibility Complex Class II Antigens Are Major Risk Factors for High-grade Cellular Rejection in Recipients of Heart Transplantation

3. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients

4. The trial to reduce alloimmunization to platelets study;Leukocyte Reduction and Ultraviolet B Irradiation of Platelets to Prevent Alloimmunization and Refractoriness to Platelet Transfusions;N Engl J Med,1997

5. Leukoreduction and ultraviolet treatment reduce both the magnitude and the duration of the HLA antibody response

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced alloresponse to platelet transfusion due to immune dysregulation following ablative chemotherapy in mice;Frontiers in Immunology;2023-11-27

2. Platelet transfusion refractoriness due to HLA alloimmunization: Evolving paradigms in mechanisms and management;Blood Reviews;2023-11